drugset / Trial / NCT00752401

Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients

NCT00752401

Phase 3 Unknown 200 enrolled Medical University of Vienna
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate the effects of Cholecalciferol (Vitamin D3) substitution on the posttransplant outcome (glomerular filtration rate as well as serum creatinine levels, number of acute rejection episodes, number of infections and C-reactive protein levels within the first year after transplantation) in vitamin D deficient kidney transplant recipients.

Timeline

Start
2009-05
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 6800 iu Oral